top of page
Untitled design.webp
Untitled design (1).webp

1.0 GET STARTED

1.1 About This Peptide

CJC-1295 (no DAC) / Ipamorelin is a peptide combination commonly discussed for its potential role in supporting endogenous growth hormone signaling and recovery-related pathways. These two compounds are frequently paired together for complementary activity.

 

CJC-1295 (no DAC) is often referenced in research for stimulating growth hormone-releasing hormone pathways, while Ipamorelin is commonly discussed as a selective ghrelin receptor agonist associated with growth hormone pulse support. Together, the blend is often referenced in performance, recovery, sleep, and body composition discussions.

 

Potential Benefits (Researched For)

 

Research and anecdotal discussions suggest CJC-1295 / Ipamorelin may influence several biological pathways related to recovery, metabolism, and hormone signaling. While most data comes from laboratory and community discussions, commonly referenced potential benefits include:

  • May support natural growth hormone pulse activity

  • May assist recovery from training-related stress

  • May contribute to lean body composition pathways

  • May support sleep quality and overnight recovery signaling

  • May assist performance and resilience support pathways

  • May support wellness-focused aging and vitality discussions

 

Human research is ongoing, and individual outcomes may vary.

Possible Minimal Side Effects (Reported)

 

In available discussions and anecdotal reporting, CJC-1295 / Ipamorelin is generally described as well tolerated. When side effects are reported, they are typically mild and may depend on dosing amount, timing, or individual sensitivity.

  • Mild water retention

  • Temporary headache

  • Increased hunger (occasionally reported)

  • Fatigue or flushing (in some cases)

 

Individual sensitivity and response may vary.

Read more about how to reduce possible minimal side effects in our FAQ.

1.2 Supplies Checklist

Before beginning, it is important to have the appropriate sterile supplies prepared. Using proper equipment supports accurate measurement, sterile handling, and safe administration.

Most users prepare the following:

  • 1 mL insulin syringes (29–31 gauge)

  • Bacteriostatic water

  • Alcohol prep pads

  • Sterile 1 mL or 3 mL syringe (often used for mixing/transferring)

  • Sharps container for proper disposal

 

Maintaining sterile technique helps reduce contamination risk.

1.3 How To Mix

What Is Reconstitution?


Reconstitution is the process of adding bacteriostatic water to the freeze-dried (lyophilized) peptide powder in order to prepare it for injection. CJC-1295 / Ipamorelin is typically supplied in powder form to preserve stability during shipping and storage.

 

Proper mixing ensures consistent concentration throughout the solution and helps maintain peptide integrity.

 

How To Mix

  1. Clean the tops of both vials with an alcohol pad.

  2. Draw the desired amount of bacteriostatic water into a sterile syringe.

  3. Slowly inject the water down the inside wall of the CJC-1295 / Ipamorelin vial.

  4. Allow the powder to dissolve. GENTLY SWIRL. DO NOT SHAKE.

 

Common Vial Sizes

 

CJC-1295 / Ipamorelin is commonly sold in:

  • 10 mg vial

  • 20 mg vial

 

Dilution volume may vary depending on personal preference and desired concentration.

1.4 Injection Basics

CJC-1295 / Ipamorelin is most commonly administered subcutaneously (under the skin). Subcutaneous injections use small insulin syringes and are generally simple to perform with proper technique.

Understanding basic injection principles can improve comfort, consistency, and overall user confidence.

 

Subcutaneous Injection Quick Guide

Topic
Quick Guide
Disposal

Use a sharps container. If unavailable, place needles in a sealed, puncture-resistant container, never loose in regular trash.

Site Rotation

Rotate injection areas daily

Injection Angle

45–90 degrees

Needle Size

29–31 gauge insulin syringe

Common Areas

Lower abdomen, outer thigh, upper arm

Injection Type

Subcutaneous (under the skin)

2.0 DOSING & STORAGE

2.1 Dosing Protocol (Commonly Reported)

Dosing approaches for CJC-1295 / Ipamorelin vary depending on individual goals, tolerance, and context of use. The example below reflects commonly reported ranges discussed in research and performance communities.

2.2 Storage Basics

Proper storage helps preserve peptide stability, potency, and shelf life. Environmental exposure can impact peptide integrity, especially after reconstitution.

Before Mixing (Powder Form)

CJC-1295 / Ipamorelin is relatively stable when stored correctly.

  • Store in a cool, dry place

  • Protect from direct sunlight

  • Avoid excessive heat exposure

 

After Mixing

 

Once reconstituted, refrigeration is recommended to maintain stability.

  • Refrigerate at 2–8°C (36–46°F)

  • Do not freeze

  • Avoid shaking

  • Keep vial upright when possible

 

Stability duration may vary depending on storage conditions and handling.

CJC 1295 (no DAC) _ Ipamorelin
Untitled design (1).webp
CJC 1295 (no DAC) / Ipamorelin

CJC-1295 (no DAC) / Ipamorelin Growth Hormone Support Peptide Guide

A simplified overview of CJC-1295 (no DAC) and Ipamorelin, focused on growth hormone signaling pathways, recovery support, preparation basics, and commonly discussed research applications.

KEY BENEFITS

  • May support natural growth hormone signaling pathways

  • Commonly discussed for recovery and restorative support

  • May assist sleep quality and overnight recovery processes

  • May support body composition and performance pathways

Learn Peptides & What They Can Do For You.

bottom of page
WELCOME TO

MIXING PEPTIDES

Research. Learn. Optimize.

Are you 18 years or older?

This website contains educational peptide research content intended for adults only.